The American Cancer Society estimates more than 164,690 new cases of prostate cancer will be diagnosed in the United States alone during 2018. Excluding non-melanoma skin cancers, prostate cancer is the most commonly diagnosed malignancy in men. In addition, this disease is the second leading cause of cancer mortality in men, exceeded only by lung cancer. Yet if diagnosed early, prostate cancer is one of the most treatable cancers. Early detection through annual PSA (protein-specific antigen) blood tests provides the opportunity to determine if brachytherapy is the most effective treatment for your prostate cancer.
Although men of any age can be diagnosed with prostate cancer, it most often affects those over age 50. Incidence rates are 70% higher in black men than for non-Hispanic white men. In addition, the risk is higher for men who have a father or brother with the disease.